Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Because salivary gland cancers (SGC) are rare and include different tumor subtypes, data on their long-term quality of life and late toxicities are sparse.

Methods: Multi-national study including SGC survivors more than 5 years after diagnosis. They completed the European Organisation for Research and Treatment of Cancer (EORTC) quality of life core questionnaire together with its head and neck cancer module and reported problems that were most bothering for them. Toxicity was clinically assessed.

Results: Altogether, 60 survivors from nine countries participated and reported dry mouth (mean score 37.2), use of painkillers (35.0), problems with sexuality (30.1), insomnia (28.9), fatigue (27.8), trismus (24.9), and sticky saliva (23.3). The most frequently mentioned long-term problem was dry mouth, mentioned by a third of all participants. The most frequent toxicities were hearing impairment, soft tissue fibrosis, dry mouth, and cranial neuropathies.

Conclusions: Dry mouth is a frequent and disturbing problem in SGC survivors.

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.28263DOI Listing

Publication Analysis

Top Keywords

dry mouth
16
quality life
12
long-term quality
8
5 years diagnosis
8
multi-national study
8
sgc survivors
8
late toxicity
4
toxicity long-term
4
survivors
4
life survivors
4

Similar Publications

Prospective Evaluation of Patient Priorities in HPV-Driven Oropharyngeal Cancer Using the Chicago Priorities Scale: Considerations for Future Clinical Trial Design.

Int J Radiat Oncol Biol Phys

September 2025

Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Nursing, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne,

Purpose: This study examined head and neck cancer treatment outcome priorities in patients with human papillomavirus-associated oropharyngeal cancer (HPVOPC) before and 12 months (12m) after (chemo)radiotherapy ([C]RT).

Methods And Materials: Eligible patients were diagnosed with HPVOPC suitable for curative-intent primary [C]RT. Study data included responses to a modified version of the Chicago Priorities Scale (CPS-modified) and select items from the MDASI Head and Neck Cancer Module (MDASI-HN).

View Article and Find Full Text PDF

Dysautonomia as a form of presentation of primary Sjögren's disease: a case series of six patients.

Immunol Res

September 2025

Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Belisario Domínguez Sección XVI, Avenida Vasco de Quiroga 15, C.P. 14080, Tlalpan, Mexico City, Mexico.

We present six patients with dysautonomia secondary to primary Sjögren's disease (pSjD) and analyze the literature regarding this topic. Case series. Patients were retrospectively recruited from a tertiary center in Mexico from 2001 to 2022 and included if they met 2016 ACR/EULAR criteria for SjD.

View Article and Find Full Text PDF

Associations of Current Cigarette, E-Cigarette, and Cannabis Use with Xerostomia.

JDR Clin Trans Res

September 2025

University of California San Francisco, School of Dentistry, San Francisco, CA, USA.

Objectives: This investigation aimed to examine the associations between xerostomia and the use of cigarettes, e-cigarettes, and cannabis in a nationally representative cross-sectional sample of adults.

Methods: Data from the Population Assessment of Tobacco and Health Study included = 29,721 United States adults (age ≥18 y) surveyed during 2022 to 2023 about xerostomia (experiencing dry mouth "frequently" or "always") and their use of 9 types of tobacco products and cannabis. Survey-weighted multivariable regression models estimated the associations of xerostomia with various specifications of cigarette, e-cigarette, and cannabis use, adjusted for sociodemographic and health status variables.

View Article and Find Full Text PDF

New-onset Autoimmune Diseases in Patients with Prurigo Nodularis: A Global-federated Retrospective Cohort Study.

Acta Derm Venereol

September 2025

Evidence-based Medicine Center, Chung Shan Medical University Hospital, Taichung, Taiwan; Orthopedics Department, Chi-Mei Medical Center, Tainan, Taiwan; Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin,

Prurigo nodularis (PN) has been associated with autoimmune diseases, though longitudinal data are limited. This study investigates the risk of autoimmune disease development in PN patients using a global electronic health record database. This retrospective cohort study analysed data from the Global Collaborative Network within the TriNetX research network.

View Article and Find Full Text PDF

Reduced TIGITCD56NK cells associate with disease progression and impaired immune regulation in primary Sjögren's syndrome.

Clin Rheumatol

September 2025

Jiangsu Key Laboratory of Clinical Immunology, Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, No. 178 Ganjiang East Road, Gusu District, Suzhou, 215021, Jiangsu, China.

Objectives: We aimed to explore the expression and clinical significance of TIGITCD56NK cells within the peripheral blood of patients with primary Sjögren's syndrome (pSS) in this study, as well as to examine the role of TIGIT in modulating NK cell function in individuals with pSS.

Methods: The percentage of TIGITCD56NK cells was detected in the peripheral blood of 76 individuals with pSS and 63 healthy controls (HCs) using flow cytometry. The percentage of TIGITCD56NK cells across various clinical features, laboratory parameters, and between active and inactive patients was analyzed.

View Article and Find Full Text PDF